Amyloid, advanced glycation end products, and dialysis related arthropathy.
作者信息
McDonald S P, Coates P T, Disney A P
机构信息
Renal Unit, Queen Elizabeth Hospital, Adelaide, South Australia.
出版信息
Ann Rheum Dis. 1998 Apr;57(4):193-5. doi: 10.1136/ard.57.4.193.
Abstract
摘要
相似文献
1
Amyloid, advanced glycation end products, and dialysis related arthropathy.淀粉样蛋白、晚期糖基化终末产物与透析相关性关节病
Ann Rheum Dis. 1998 Apr;57(4):193-5. doi: 10.1136/ard.57.4.193.
2
New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.透析相关性淀粉样变发病机制的新进展：晚期糖基化终产物修饰的β2-微球蛋白在骨与关节破坏中的作用
Nephrol Dial Transplant. 1996;11 Suppl 2:140-3. doi: 10.1093/ndt/11.supp2.140.
3
Beta2-microglobulin and renal bone disease.β2-微球蛋白与肾性骨病
Perit Dial Int. 1999;19 Suppl 2:S413-6.
4
Dialysis arthropathy.透析性关节病
Lancet. 1988;1(8575-6):27-8.
5
Beta 2-microglobulin-related amyloidosis: where do we stand?β2微球蛋白相关淀粉样变性：我们目前的状况如何？
Nephrol Dial Transplant. 1995;10(2):155-7.
6
Advanced glycation of beta 2-microglobulin in the pathogenesis of bone lesions in dialysis-associated amyloidosis.β2-微球蛋白的晚期糖基化在透析相关性淀粉样变骨病变发病机制中的作用
Nephrol Dial Transplant. 1996;11 Suppl 3:86-90. doi: 10.1093/ndt/11.supp3.86.
7
[Amyloidosis in patients undergoing long-term hemodialysis: elucidation of etiological mechanism and therapeutic stratigy].[长期血液透析患者的淀粉样变性：病因机制的阐明与治疗策略]
Nihon Naika Gakkai Zasshi. 2005 Feb 20;94 Suppl:56-60. doi: 10.2169/naika.94.suppl_56.
8
Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.β2-微球蛋白透析淀粉样变及其形成：3-脱氧葡萄糖醛酮和晚期糖基化终产物的作用
Nephron. 1997;76(4):373-91. doi: 10.1159/000190218.
9
Beta 2-microglobulin modified with the AGE products of the Maillard reaction in dialysis-related amyloidosis.在透析相关性淀粉样变中，被美拉德反应的晚期糖基化终末产物修饰的β2-微球蛋白
Contrib Nephrol. 1995;112:52-64. doi: 10.1159/000424092.
10
Diagnosis, pathogenesis, and treatment of dialysis-related amyloidosis.透析相关性淀粉样变的诊断、发病机制及治疗
Miner Electrolyte Metab. 1999 Jan-Apr;25(1-2):114-7. doi: 10.1159/000057432.
本文引用的文献
1
Beta 2-microglobulin associated amyloidosis: a vanishing complication of long-term hemodialysis?β2-微球蛋白相关淀粉样变性：长期血液透析中逐渐消失的并发症？
Kidney Int. 1997 Oct;52(4):1077-83. doi: 10.1038/ki.1997.431.
2
Histological prevalence of beta 2-microglobulin amyloidosis in hemodialysis: a prospective post-mortem study.血液透析中β2-微球蛋白淀粉样变的组织学患病率：一项前瞻性尸检研究。
Kidney Int. 1997 Jun;51(6):1928-32. doi: 10.1038/ki.1997.262.
3
High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis.高通量血液透析可延缓透析相关淀粉样变的临床表现。
Am J Nephrol. 1996;16(6):484-8. doi: 10.1159/000169048.
4
Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group.不同膜和透析技术对患者治疗耐受性及营养参数的影响。意大利透析协作研究组。
Kidney Int. 1996 Oct;50(4):1293-302. doi: 10.1038/ki.1996.441.
5
Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis.在透析相关性淀粉样变中，正常且完整的β2微球蛋白作为淀粉样蛋白发生聚合。
Kidney Int. 1996 Oct;50(4):1262-7. doi: 10.1038/ki.1996.436.
6
Inflammatory effects of peritoneal dialysis: evidence of systemic monocyte activation.腹膜透析的炎症效应：全身单核细胞活化的证据。
Kidney Int. 1996 Feb;49(2):506-11. doi: 10.1038/ki.1996.72.
7
Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology.肾移植对透析相关淀粉样沉积物及症状学的长期影响。
Kidney Int. 1996 Jul;50(1):282-9. doi: 10.1038/ki.1996.313.
8
New aspects in the pathogenesis of dialysis-related amyloidosis: role of beta 2-microglobulin modified with advanced glycation end products in bone and joint destruction.透析相关性淀粉样变发病机制的新进展：晚期糖基化终产物修饰的β2-微球蛋白在骨与关节破坏中的作用
Nephrol Dial Transplant. 1996;11 Suppl 2:140-3. doi: 10.1093/ndt/11.supp2.140.
9
Functional study of hands among patients dialysed for more than 10 years.透析超过10年患者手部的功能研究
Nephrol Dial Transplant. 1993;8(4):347-51.
10
Is beta 2-microglobulin a mediator of bone disease?β2-微球蛋白是骨病的介质吗？
Kidney Int. 1995 Jan;47(1):1-6. doi: 10.1038/ki.1995.1.
Zotero 插件